Development of [ 18F]FRP-170 injection for imaging hypoxia by PET

Kakuigaku

Volumn 42, Issue 1, 2005, Pages 1-10

  Ishikawa, Yoichi ^a   Funaki, Yoshihito ^a   Iwata, Ren ^a   Furumoto, Shozo ^a   Nakata, Eiko ^a   Kudo, Yukitsuka ^a   Kaneta, Tomohiro ^a   Hakamatsuka, Takashi ^a   Takai, Yoshihiro ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Automated synthesis; F 18; FRP 170; Hypoxic cell maker; PET radiopharmaceutical

Indexed keywords

1 [2 FLUORO 1 (HYDROXYMETHYL)ETHOXY]METHYL 2 NITROIMIDAZOLE; 2 NITROIMIDAZOLE DERIVATIVE; FLUORINE 18; FRP 170; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; FRP-170; NITROIMIDAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; AUTOMATION; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIOACTIVITY; ANIMAL; ANOXIA; DRUG DESIGN; DRUG DOSAGE FORM; INTRAVENOUS DRUG ADMINISTRATION; MOUSE STRAIN; MUTAGEN TESTING; RAT; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; ANOXIA; DOSAGE FORMS; DRUG DESIGN; FLUORINE RADIOISOTOPES; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED STRAINS; MUTAGENICITY TESTS; NITROIMIDAZOLES; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 20144389636     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. Appl Radiat Isot 1986; 37: 599-605.
2. Grierson JR, Link JM, Mathis CA, Rasey JS, Krohn KA: A radiosynthesis of fluorine-18 fluoromisonidazole. J Nucl Med 1989; 30: 343-350,
3. Yang DJ, Wallace S, Cherif A, Gretzer MB, Kim EE, Podoloff DA: Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology 1995; 194: 795-800.
4. 18F]fluoroetanidazole: a potential new tracer for imaging hypoxia. Nucl Med Biol 1997; 24: 755-760.
5. 18F]-EF1. Appl Radiat Isot 1999; 51: 643-650.
6. 18F]-labeled EF3 [2-(2-nitroimidazol-1-y1)-N-(3,3,3- trifluoropropyl)-acetamide], a marker for PET detection of hypoxia, Bioorg Med Chem 2001; 9: 665-675.
7. 18F]-EF5, a maker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl Radiat Isot 2001; 54: 73-80.
8. Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, et al: Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl) ethoxy]methyl-2-nitroimidazole (RP-170). Int J Radiat Oncol Biol Phys 1989; 17: 575-581.
9. 18F]FENI), a potential agent for imaging hypoxic tissues by PET. J Label Compd Radiopharm 2000; 43: 785-793.
10. 18F-FRP170. J Nucl Med 2002; 43: 109-116.
11. Bergström M, Grahnen A, Långsrtöm B: Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development. Eur J Clin Pharmacol 2003; 59: 357-366.
12. 18F]FRP-170 by on-column hydrolysis. Appl Radiat Isot in press.
13. Iwata R, Yamazaki S, Ido T: Intelligent control of liquid transfer for the automated synthesis of positron emitting radiopharmaceuticals. Appl Radiat Isot 1990; 41: 509-511.
14. Stabin MG: MIRDOSE: computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.
15. 18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J Label Compd Radiopharm 2002; 45: 435-447.
16. 11C]Ro 15-4513. Nucl Med Biol 2003; 30: 389-395.
17. 18F-Fluorocholine. J Nucl Med 2002; 43: 92-96.
18. 18F-labeled radiopharmaceuticals. J Radiat Res 1991; 32: 243-261.